IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL5.94▲ 0.13% USD/MXN19.06▼ 0.11% USD/CLP1,016▼ 0.06% USD/COP3,413▲ 1.66% USD/PEN3.44▼ 0.14% USD/ARS1,568▲ 0.20% USD/UYU40.61▲ 3.16% USD/PYG6,212▲ 2.85% USD/BOB11.64▲ 3.02% USD/DOP59.71▼ 0.48% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO36.62▲ 0.34% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 2.60% USD/TTD6.70▲ 2.00% EUR/BRL6.54▲ 1.36% BRENT 89.48 ▼ 2.72% WTI 82.44 ▼ 0.93% IRON ORE 161.91 — — COPPER 5.54 ▼ 1.56% GOLD 3,576 ▼ 2.97% SILVER 42.21 ▼ 4.76% SOY 1,213 ▲ 0.41% CORN 450.75 ▲ 2.68% WHEAT 596.00 ▲ 3.07% COFFEE 271.80 ▼ 3.63% SUGAR 16.99 ▼ 0.99% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.55 ▲ 4.74% COCOA 5,230 ▲ 3.30% BEEF 223.00 ▲ 1.47% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,713.60 ▼ 0.64% MERVAL 2,848,945 — — USD/BRL 5.94 ▲ 0.01% USD/MXN 19.06 ▼ 0.13% USD/CLP 1,016 ▼ 0.09% USD/COP 3,428 ▲ 2.10% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,565 ▲ 0.01% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 3.02% USD/DOP 59.52 ▼ 0.80% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 ▲ 0.34% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 2.60% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.52 ▲ 1.16% BRENT 89.48 ▼ 2.72% WTI 82.44 ▼ 0.93% IRON ORE 161.91 — — COPPER 5.54 ▼ 1.56% GOLD 3,576 ▼ 2.97% SILVER 42.21 ▼ 4.76% SOY 1,213 ▲ 0.41% CORN 450.75 ▲ 2.68% WHEAT 596.00 ▲ 3.07% COFFEE 271.80 ▼ 3.63% SUGAR 16.99 ▼ 0.99% ORANGE JUICE 131.95 ▲ 1.85% COTTON 79.55 ▲ 4.74% COCOA 5,230 ▲ 3.30% BEEF 223.00 ▲ 1.47% CATTLE 335.85 ▼ 0.34% LITHIUM 54.33 ▼ 2.23% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74%
since 2009
Friday, November 20, 2026

Covid-19 Brazil

Brazilian Pharmaceutical Company to Apply for Emergency Use of Russian Sputnik V Vaccine

By · · 3 min read
On Wednesday, January 13th, União Química pharmaceutical company and the Russian Direct Investment Fund (RDIF) announced they will apply for emergency use authorization of the Russian Sputnik V vaccine to the National Health Surveillance Agency (ANVISA) later this week, according to a statement released by the RDIF.
On Wednesday, January 13th, União Química announced they will apply for emergency use authorization of the Russian Sputnik V vaccine.

RIO DE JANEIRO, BRAZIL – On Wednesday, January 13th, União Química pharmaceutical company and the Russian Direct Investment Fund (RDIF) announced they will apply for emergency use authorization of the Russian Sputnik V vaccine to the National Health Regulatory Agency (ANVISA) later this week, according to a statement released by the RDIF.

However, the vaccine’s clinical trials need to be in phase 3 for the application to be possible. Last Friday, January 8th, ANVISA published a note explaining that União Química “requested authorization to conduct phase 3 clinical trials in Brazil” on December 29th, 2020, but authorization for this phase to begin has not yet been granted.

RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

“ANVISA began the analysis, but identified the need for additional data, which were requested to the laboratory. To date, União Química has not submitted such data to ANVISA. The current status of the application is awaiting the submission of the data requested in the technical requirement,” reads the agency’s text.

It will therefore be necessary to surmount this deadlock before requesting an emergency use. According to the pharmaceutical company, in addition to Russia, the vaccine has been approved for emergency use in countries such as Argentina, Bolivia, Algeria, Serbia and Palestine.

Agreement for sending of doses

União Química and RDIF have also announced an agreement that provides for the sending of ten million ready doses of the Sputnik V vaccine to Brazil by March, with a first delivery in January.

Last Sunday, January 10th, the pharmaceutical company announced it would initiate the production of more doses of the vaccine “still in January”, through the Bthek Plant in Brasília. A total of eight million doses per month are expected to be supplied in the first quarter of this year.

The Sputnik V was the first Covid-19 vaccine to be registered worldwide, in August, amid controversies. Later, in December, Russia announced the vaccine’s efficacy, which stood at 91.4%. However, the study details have not been published nor peer-reviewed.

Situation in Brazil

Should the Russian vaccine be approved and endorsed by ANVISA to be administered to the population, it could be another option within the federal government’s immunization program. However, there are no agreements in place yet for the purchase of the immunizer once it is ready.

According to the Ministry of Health, Brazil currently has 354 million doses of vaccines against Covid-19 guaranteed for 2021 – 254 million doses of which refer to the Oxford/AstraZeneca vaccine, which will be produced domestically by the Oswaldo Cruz Foundation (Fiocruz) and 100 million doses of the CoronaVac, the Chinese Sinovac vaccine in partnership with the Butantan.

The Ministry plans to have at least eight million doses available for immunization as early as January. Of this total, six million would be CoronaVac doses, which are currently stored at the Butantan Institute. The other two million would be the Oxford/AstraZeneca’s vaccine, which according to Minister of Health Eduardo Pazuello are being shipped from India this Wednesday.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.